2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Réeff J et al. | Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. | 2015 | Int J Pharm | pmid:25934426 |
| Borgheti-Cardoso LN et al. | An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. | 2015 | Eur J Pharm Sci | pmid:25917525 |
| Corte-Real J et al. | Selective factors governing in vitro β-carotene bioaccessibility: negative influence of low filtration cutoffs and alterations by emulsifiers and food matrices. | 2014 | Nutr Res | pmid:25476193 |
| Quiñones OG et al. | In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. | 2014 | Drug Dev Ind Pharm | pmid:23826859 |
| Thapa RK and Yoo BK | Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. | 2014 | J Dermatolog Treat | pmid:23210668 |
| Morsi NM et al. | Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. | 2014 | Eur J Pharm Biopharm | pmid:23688805 |
| Esposito E et al. | Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. | 2014 | Eur J Pharm Biopharm | pmid:24361485 |
| Lopez-Bermudez J et al. | Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae. | 2014 | Vaccine | pmid:25446832 |
| Baskaran R et al. | Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity. | 2014 | Int J Nanomedicine | pmid:25061290 |
| Tiossi RF et al. | In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. | 2014 | Eur J Pharm Biopharm | pmid:24509413 |